Role of Stereotactic body radiation therapy in the management of oligometastatic renal cell carcinoma

Kidney cancer has been increasing by 1.7% annually. Renal cell carcinoma (RCC) is the most common kidney cancer, and can metastasize. Our aim is to analyze patients treated with Stereotactic Body Radiation Therapy (SBRT) on metastases from RCC.

Source: The Journal of Urology - September 1, 2018 Category: Urology & Nephrology Authors: Ciro Franzese, Davide Franceschini, Lucia Di Brina, Giuseppe Roberto D ’Agostino, Pierina Navarria, Tiziana Comito, Pietro Mancosu, Stefano Tomatis, Marta Scorsetti Source Type: research